Pharmaceutical compositions and method of using levodopa and carbidopa
US8815950B2 · kind B2 · utility
8Cited by
11References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 17, 2005 |
| Grant date | Aug 26, 2014 |
| Priority date | — |
| Expiry date | Jul 22, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/198
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to stable dosage forms and compositions of levodopa and carbidopa for the treatment of patients suffering from Parkinson's disease. The dosage forms and compositions comprise both solid and liquid formulations and result in stable pharmaceutical products. Such dosage forms and compositions comprise a metal chelator and a levodopa concentration from about 1 mg/mL to about 30 mg/mL.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.